Home > PJ (current issue) > The Society / Daily News | Search

The Pharmaceutical Journal
Vol 273 No 7307 p69
10 July 2004


Society summary


Council rescinds its decision to review the Government's requirements on regulation

The Council of the Royal Pharmaceutical Society has rescinded a decision made at its June meeting to set up a committee to review evidence relating to the Government's requirements in regard to the Society's regulatory function.

The Council’s decision had been made on the motion of Nicholas Wood. The second of six motions proposed by Mr Wood, it read: “That a committee, the members of which are to be confirmed by Council, be formed to review urgently all correspondence and reports of meetings between representatives of the Department of Health, the Privy Council office, Council for the Regulation of Healthcare Professionals and the Society, to establish the requirements of government in regard to the regulatory functions of the Society, such a committee to provide an interim report as soon as possible and a final report by the December 2004 Council meeting” (PJ, 19 June, p779).

Having passed the motion, the Council decided to defer the establishment of such a committee until after its discussion at the strategy days on 29 and 30 June.

When the special Council meeting on 30 June considered what further action may be required in relation to the motion, the President noted that the Council had already seen a whole series of documents between the Department of Health and the Privy Council, which had been laid out in the committee rooms over the previous few days.

Mr Argomandkhah said that the Council should find out whether there were any lessons to be learnt from the processes that had got it into the current situation. An audit by a group of senior Council members would be beneficial.

The Secretary and Registrar pointed out that the resource implications were considerable. The Society had much work to do in looking at the requirements for new regulations and rules. The Council, in terms of audit, should consider where it placed resources.

The Vice-President, on a point of order, said that the use of the term “senior Council members” was confusing.

Christine Glover said that the motion should go.

The President disagreed. The motion had been agreed and the Council was being asked to consider was what further action may be required.

Digby Emson suggested that, given the information already available, no further action was required. The Council should thank the Officers for providing the information swiftly and efficiently.

Gill Hawksworth said that it was not the Officers who had provided the information. Two members of staff, Elaine Mulingani and Christine Gray, had worked extremely hard for a number of days laying out the information in the committee room. It had taken a vast amount of time and effort and resource to put it together, but few people had been to look at it.

The President thought there was a proposal [to rescind the motion] that he was happy to take. He asked if that was agreed.

The Secretary and Registrar pointed out that the Council needed to suspend standing orders to withdraw a motion that had already been carried. On a vote, the Council agreed to suspend standing orders. The President then proposed the withdrawal of the motion, which was agreed.

Back to Top


©The Pharmaceutical Journal